Ankylosing Spondylitis
📧 Sign up to get email alerts when something new happens for Ankylosing Spondylitis.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS research · 2017-12-06Clinical Trial Update: The Effect of Acupuncture in Treating Chronic Low-back Pain [NA]
Clinical trial update on the effects of acupuncture for chronic low-back pain. Conditions listed include Ankylosing Spondylitis and Low back…
-
CLINICAL_TRIALS trial_result · 2017-11-13Clinical Trial Update: A Study of Golimumab in Participants With Active Ankylosing Spondylitis [Phase 3]
Phase 3 clinical trial of golimumab in adults with active ankylosing spondylitis has completed, and results were posted in 2017. The study w…
-
CLINICAL_TRIALS trial_result · 2017-11-01Clinical Trial Update: An Observational Study of Infliximab in Participants Suffering From Ankylosing Spondylitis With Hip Involvement
This clinical trial update notes an observational study evaluating infliximab in participants with Ankylosing Spondylitis involving the hip …
-
CLINICAL_TRIALS research · 2017-10-30Clinical Trial Update: Effect of Biological Disease Modifying Anti Rheumatic Drug (bDMARD) Treatment on Spinal Fracture Incidence in Patients With Ankylosing Spondylitis (AS)
Completed clinical trial evaluating whether biological DMARD therapy affects spinal fracture incidence in patients with ankylosing spondylit…
-
FDA approval · 2017-08-22FDA Approved: ALEVE GELCAPS — Supplemental Application (Bayer HealthCare LLC.)
FDA approved a supplemental application for ALEVE GELCAPS (naproxen sodium) by Bayer HealthCare LLC., expanding the product through a supple…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2017-08-08Clinical Trial Update: Dose Ranging Study to Evaluate the Efficacy and Safety of SAR153191 (REGN88) in Patients With Ankylosing Spondylitis [Phase 2]
A Phase 2 dose-ranging trial evaluating efficacy and safety of SAR153191 (REGN88) in patients with ankylosing spondylitis has completed and …
-
CLINICAL_TRIALS research · 2017-07-27Clinical Trial Update: Pharmacist CVD Intervention for Patients With Inflammatory Arthritis [NA]
Clinical trial update describing a pharmacist-led intervention to reduce cardiovascular risk in patients with inflammatory arthritis, includ…
-
CLINICAL_TRIALS trial_result · 2017-07-26Clinical Trial Update: Prevention of Arthritis-Related Work Disability [NA]
A completed clinical trial update on preventing arthritis-related work disability involving rheumatoid arthritis, systemic lupus erythematos…
-
FDA approval · 2017-06-22FDA Approved: SIMPONI — Supplemental Application (Janssen Biotech, Inc.)
FDA approved a supplemental application for Simponi (golimumab) submitted by Janssen Biotech, Inc.
-
CLINICAL_TRIALS trial_result · 2017-06-21Clinical Trial Update: Extension Study for Long Term Evaluation of SAR153191 (REGN88) in Patients With Ankylosing Spondylitis [Phase 2]
An extension study of REGN88 (SAR153191) in ankylosing spondylitis was terminated in Phase 2, with results posted in 2017.
-
CLINICAL_TRIALS trial_result · 2017-05-11Clinical Trial Update: A Study of the Efficacy and Tolerance of Remicade in the Treatment of Active Ankylosing Spondylitis (Study P04042)(COMPLETED) [Phase 4]
This document reports the completion of a Phase 4 trial evaluating the efficacy and tolerability of Remicade (infliximab) in patients with a…
-
CLINICAL_TRIALS trial_result · 2017-05-11Clinical Trial Update: Growth Factor Concentration to Predict an Ankylosing Spondylitis Patient's Response to Infliximab (Study P04041)(COMPLETED) [Phase 4]
A Phase 4 study investigating whether growth factor concentrations can predict response to infliximab in ankylosing spondylitis has complete…
-
CLINICAL_TRIALS trial_result · 2017-05-08Clinical Trial Update: Efficacy and Safety of Risedronate (Actonel), a Third Generation Bisphosphonate in Patients With Ankylosing Spondylitis: a Phase 2 Pilot Study [Phase 2]
This Phase 2 pilot study evaluated the efficacy and safety of risedronate (Actonel) in patients with ankylosing spondylitis; the trial has c…
-
FDA approval · 2017-04-21FDA Approved: RENFLEXIS — Original Application (Organon LLC)
The FDA approved RENFLEXIS (infliximab) from Organon LLC based on an original application, making it a biosimilar to Remicade. The approval …
-
FDA approval · 2017-04-13FDA Approved: PIROXICAM — Original Application (Unichem Pharmaceuticals (USA), Inc.)
FDA approved Unichem Pharmaceuticals (USA), Inc.'s Original Application for piroxicam, authorizing a generic version of the NSAID piroxicam.
-
CLINICAL_TRIALS research · 2017-04-04Clinical Trial Update: The Effect of Acupuncture Protocol Involving in Weizhong (BL4) and Huantiao (GB30) Points in Treating Ankylosing Spondylitis [NA]
A clinical trial investigating acupuncture using BL4 (Weizhong) and GB30 (Huantiao) points for ankylosing spondylitis; current status is unk…
-
CLINICAL_TRIALS trial_result · 2017-03-24Clinical Trial Update: Evaluation of Low Dose Infliximab in Ankylosing Spondylitis (Study P04352) [Phase 3]
Phase 3 trial update indicates completion of evaluating low-dose infliximab for ankylosing spondylitis (Study P04352) sponsored by Merck Sha…
-
FDA approval · 2017-03-10FDA Approved: NAPROXEN — Supplemental Application (Zameer Pharmaceuticals LLC)
FDA approved a supplemental application for Naproxen by Zameer Pharmaceuticals LLC.
-
CLINICAL_TRIALS trial_result · 2017-03-09Clinical Trial Update: Assial - Anti Tnf Treatment in Ankylosing Spondylitis: an Observational Cohort Study in Italy
Pfizer-sponsored observational cohort study in Italy evaluating anti-TNF therapy for Ankylosing Spondylitis; results were posted in 2017.
-
CLINICAL_TRIALS trial_result · 2017-03-06Clinical Trial Update: Impact of Adalimumab (Humira®) Therapy on Selected Health Care Resource Utilization and Sick Leave in Patients With Ankylosing Spondylitis in Clinical Practice
A completed clinical trial evaluated how adalimumab (Humira) therapy influences health care resource use and sick leave in patients with ank…
-
CLINICAL_TRIALS withdrawal · 2017-03-06Clinical Trial Update: Study of Anti-Viral Prophylaxis for HBsAg(+) or HBcAb(+)/HBsAb(-) Patients Starting Anti-TNFα [Phase 3]
A Phase 3 trial evaluating antiviral prophylaxis for HBsAg-positive or HBcAb-positive/HBsAb-negative patients starting anti-TNF therapy has …
-
CLINICAL_TRIALS trial_result · 2017-02-23Clinical Trial Update: Adalimumab in Alleviating Inflammation in Patients With Axial Spondyloarthritis [Phase 4]
A Phase 4 clinical trial update evaluating the anti-TNF agent adalimumab for reducing inflammation in axial spondyloarthritis, including ank…
-
CLINICAL_TRIALS trial_result · 2017-02-15Clinical Trial Update: Effects of Aerobic Training in Patients With Ankylosing Spondylitis [Phase 3]
A Phase 3 trial evaluating aerobic training in patients with Ankylosing Spondylitis has completed.
-
CLINICAL_TRIALS trial_result · 2017-02-06Clinical Trial Update: A Multicenter, Postmarketing Study Evaluating the Concentration of Cimzia® in Mature Breast Milk of Lactating Mothers [Phase 1]
A multicenter Phase 1 postmarketing study evaluating the concentration of certolizumab pegol (Cimzia) in mature breast milk of lactating mot…
-
CLINICAL_TRIALS trial_result · 2017-01-27Clinical Trial Update: 16 Week Efficacy and 2 Year Long Term Safety and Efficacy of Secukinumab in Patients With Active Ankylosing Spondylitis [Phase 3]
A Phase 3 trial update evaluating 16-week efficacy of secukinumab in active ankylosing spondylitis. The report also covers two-year long-ter…